Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease.
Ontology highlight
ABSTRACT: Chronic graft versus host disease (cGVHD) is a debilitating and costly complication following haemopoietic stem cell transplantation (HSCT). This study describes the economic burden associated with cGVHD. Direct costs associated with specialised healthcare utilisation (inpatient admissions and outpatient visits), as well as indirect costs associated with sickness absence-associated productivity loss were estimated in patients who underwent allogeneic HSCT in Sweden between 2006 and 2015, linking population-based health and economic registers. To capture the period of chronic GVHD, patients were included who survived > 182 days post-HSCT (start of follow-up), and cGVHD was classified based on patient treatment records to correct for any diagnosis underreporting. Patients were classified as
SUBMITTER: Schain F
PROVIDER: S-EPMC7822787 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA